Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
29.97
-0.51 (-1.67%)
Aug 14, 2025, 8:11 AM - Market open

Amphastar Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
720.74712.81593.24498.99437.77349.85
Upgrade
Other Revenue
1.9419.1551.16---
Upgrade
Revenue
722.68731.97644.4498.99437.77349.85
Upgrade
Revenue Growth (YoY)
1.37%13.59%29.14%13.98%25.13%8.53%
Upgrade
Cost of Revenue
362.35358.11290.57250.13238.03206.51
Upgrade
Gross Profit
360.33373.86353.82248.86199.74143.34
Upgrade
Selling, General & Admin
99.2794.5280.3966.5967.1262.86
Upgrade
Research & Development
79.473.9173.7474.7760.9367.23
Upgrade
Operating Expenses
178.66168.44154.13141.36128.05130.09
Upgrade
Operating Income
181.67205.42199.69107.571.6913.25
Upgrade
Interest Expense
-31.89-35.34-33.06-1.85-0.89-0.37
Upgrade
Interest & Investment Income
8.7310.615.461.320.60.64
Upgrade
Earnings From Equity Investments
--0.57-1.98-1.18-0.21-
Upgrade
Other Non Operating Income (Expenses)
3.339.081.979.0713.546.22
Upgrade
EBT Excluding Unusual Items
161.84189.19172.08114.8684.7319.74
Upgrade
Asset Writedown
---2.7---
Upgrade
Legal Settlements
----1-12.8
Upgrade
Other Unusual Items
-----1.8-2.3
Upgrade
Pretax Income
161.84189.19169.38114.8683.934.64
Upgrade
Income Tax Expense
27.1329.6731.8323.4820.633.54
Upgrade
Earnings From Continuing Operations
134.71159.52137.5591.3963.31.1
Upgrade
Minority Interest in Earnings
-----1.190.31
Upgrade
Net Income
134.71159.52137.5591.3962.121.4
Upgrade
Net Income to Common
134.71159.52137.5591.3962.121.4
Upgrade
Net Income Growth
-19.10%15.98%50.51%47.12%4327.37%-97.13%
Upgrade
Shares Outstanding (Basic)
484848494847
Upgrade
Shares Outstanding (Diluted)
505253525049
Upgrade
Shares Change (YoY)
-5.10%-1.78%1.09%5.31%1.34%-1.57%
Upgrade
EPS (Basic)
2.823.292.851.881.300.03
Upgrade
EPS (Diluted)
2.683.062.601.741.250.03
Upgrade
EPS Growth
-14.81%17.69%49.43%39.20%4090.97%-96.96%
Upgrade
Free Cash Flow
112.19172.35145.3465.1570.5423.41
Upgrade
Free Cash Flow Per Share
2.233.312.741.241.420.48
Upgrade
Gross Margin
49.86%51.08%54.91%49.87%45.63%40.97%
Upgrade
Operating Margin
25.14%28.06%30.99%21.54%16.38%3.79%
Upgrade
Profit Margin
18.64%21.79%21.34%18.31%14.19%0.40%
Upgrade
Free Cash Flow Margin
15.52%23.54%22.55%13.06%16.11%6.69%
Upgrade
EBITDA
236.73258.39237.72132.2794.9534.78
Upgrade
EBITDA Margin
32.76%35.30%36.89%26.51%21.69%9.94%
Upgrade
D&A For EBITDA
55.0652.9738.0424.7723.2721.53
Upgrade
EBIT
181.67205.42199.69107.571.6913.25
Upgrade
EBIT Margin
25.14%28.06%30.99%21.54%16.38%3.79%
Upgrade
Effective Tax Rate
16.77%15.68%18.79%20.44%24.58%76.34%
Upgrade
Revenue as Reported
722.68731.97644.4498.99437.77-
Upgrade
Advertising Expenses
-10.510.48.78.15.8
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q